Global Oncology Based Preclinical CRO Market Growth (Status and Outlook) 2022-2028

As the global economy mends, the 2021 growth of Oncology Based Preclinical CRO will have significant change from previous year. According to our (LP Information) latest study, the global Oncology Based Preclinical CRO market size is USD  million in 2022 from USD 372 million in 2021, with a change of  % between 2021 and 2022. The global Oncology Based Preclinical CRO market size will reach USD 867.9 million in 2028, growing at a CAGR of 12.9% over the analysis period.

The United States Oncology Based Preclinical CRO market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Oncology Based Preclinical CRO market, reaching US$  million by the year 2028. As for the Europe Oncology Based Preclinical CRO landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Oncology Based Preclinical CRO players cover Crown Bioscience, Charles River, ICON, and Eurofins Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based Preclinical CRO market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
    Blood Cancer
    Solid Tumors
    Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
    In Vitro
    In Vivo

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Crown Bioscience
    Charles River
    ICON
    Eurofins Scientific
    Taconic Biosciences
    Covance
    EVOTEC
    The Jackson Laboratory
    MI Bioresearch
    Champion Oncology
    Wuxi AppTec.
    Xentech
    Living Tumor Laboratory

List of Tables
    Table 1. Oncology Based Preclinical CRO Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Blood Cancer
    Table 3. Major Players of Solid Tumors
    Table 4. Major Players of Others
    Table 5. Oncology Based Preclinical CRO Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 6. Global Oncology Based Preclinical CRO Market Size by Type (2017-2022) & ($ Millions)
    Table 7. Global Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2022)
    Table 8. Oncology Based Preclinical CRO Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Oncology Based Preclinical CRO Market Size by Application (2017-2022) & ($ Millions)
    Table 10. Global Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2022)
    Table 11. Global Oncology Based Preclinical CRO Revenue by Players (2020-2022) & ($ Millions)
    Table 12. Global Oncology Based Preclinical CRO Revenue Market Share by Player (2020-2022)
    Table 13. Oncology Based Preclinical CRO Key Players Head office and Products Offered
    Table 14. Oncology Based Preclinical CRO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 15. New Products and Potential Entrants
    Table 16. Mergers & Acquisitions, Expansion
    Table 17. Global Oncology Based Preclinical CRO Market Size by Regions 2017-2022 & ($ Millions)
    Table 18. Global Oncology Based Preclinical CRO Market Size Market Share by Regions (2017-2022)
    Table 19. Americas Oncology Based Preclinical CRO Market Size by Country (2017-2022) & ($ Millions)
    Table 20. Americas Oncology Based Preclinical CRO Market Size Market Share by Country (2017-2022)
    Table 21. Americas Oncology Based Preclinical CRO Market Size by Type (2017-2022) & ($ Millions)
    Table 22. Americas Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2022)
    Table 23. Americas Oncology Based Preclinical CRO Market Size by Application (2017-2022) & ($ Millions)
    Table 24. Americas Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2022)
    Table 25. APAC Oncology Based Preclinical CRO Market Size by Region (2017-2022) & ($ Millions)
    Table 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Region (2017-2022)
    Table 27. APAC Oncology Based Preclinical CRO Market Size by Type (2017-2022) & ($ Millions)
    Table 28. APAC Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2022)
    Table 29. APAC Oncology Based Preclinical CRO Market Size by Application (2017-2022) & ($ Millions)
    Table 30. APAC Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2022)
    Table 31. Europe Oncology Based Preclinical CRO Market Size by Country (2017-2022) & ($ Millions)
    Table 32. Europe Oncology Based Preclinical CRO Market Size Market Share by Country (2017-2022)
    Table 33. Europe Oncology Based Preclinical CRO Market Size by Type (2017-2022) & ($ Millions)
    Table 34. Europe Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2022)
    Table 35. Europe Oncology Based Preclinical CRO Market Size by Application (2017-2022) & ($ Millions)
    Table 36. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2022)
    Table 37. Middle East & Africa Oncology Based Preclinical CRO Market Size by Region (2017-2022) & ($ Millions)
    Table 38. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region (2017-2022)
    Table 39. Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2022)
    Table 41. Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2022)
    Table 43. Key Market Drivers & Growth Opportunities of Oncology Based Preclinical CRO
    Table 44. Key Market Challenges & Risks of Oncology Based Preclinical CRO
    Table 45. Key Industry Trends of Oncology Based Preclinical CRO
    Table 46. Global Oncology Based Preclinical CRO Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 47. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Regions (2023-2028)
    Table 48. Global Oncology Based Preclinical CRO Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 49. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Type (2023-2028)
    Table 50. Global Oncology Based Preclinical CRO Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 51. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Application (2023-2028)
    Table 52. Crown Bioscience Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 53. Crown Bioscience Oncology Based Preclinical CRO Product Offered
    Table 54. Crown Bioscience Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 55. Crown Bioscience Main Business
    Table 56. Crown Bioscience Latest Developments
    Table 57. Charles River Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 58. Charles River Oncology Based Preclinical CRO Product Offered
    Table 59. Charles River Main Business
    Table 60. Charles River Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 61. Charles River Latest Developments
    Table 62. ICON Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 63. ICON Oncology Based Preclinical CRO Product Offered
    Table 64. ICON Main Business
    Table 65. ICON Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. ICON Latest Developments
    Table 67. Eurofins Scientific Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 68. Eurofins Scientific Oncology Based Preclinical CRO Product Offered
    Table 69. Eurofins Scientific Main Business
    Table 70. Eurofins Scientific Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Eurofins Scientific Latest Developments
    Table 72. Taconic Biosciences Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 73. Taconic Biosciences Oncology Based Preclinical CRO Product Offered
    Table 74. Taconic Biosciences Main Business
    Table 75. Taconic Biosciences Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Taconic Biosciences Latest Developments
    Table 77. Covance Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 78. Covance Oncology Based Preclinical CRO Product Offered
    Table 79. Covance Main Business
    Table 80. Covance Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Covance Latest Developments
    Table 82. EVOTEC Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 83. EVOTEC Oncology Based Preclinical CRO Product Offered
    Table 84. EVOTEC Main Business
    Table 85. EVOTEC Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. EVOTEC Latest Developments
    Table 87. The Jackson Laboratory Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 88. The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
    Table 89. The Jackson Laboratory Main Business
    Table 90. The Jackson Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. The Jackson Laboratory Latest Developments
    Table 92. MI Bioresearch Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 93. MI Bioresearch Oncology Based Preclinical CRO Product Offered
    Table 94. MI Bioresearch Main Business
    Table 95. MI Bioresearch Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. MI Bioresearch Latest Developments
    Table 97. Champion Oncology Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 98. Champion Oncology Oncology Based Preclinical CRO Product Offered
    Table 99. Champion Oncology Main Business
    Table 100. Champion Oncology Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. Champion Oncology Latest Developments
    Table 102. Wuxi AppTec. Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 103. Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
    Table 104. Wuxi AppTec. Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 105. Wuxi AppTec. Main Business
    Table 106. Wuxi AppTec. Latest Developments
    Table 107. Xentech Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 108. Xentech Oncology Based Preclinical CRO Product Offered
    Table 109. Xentech Main Business
    Table 110. Xentech Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 111. Xentech Latest Developments
    Table 112. Living Tumor Laboratory Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
    Table 113. Living Tumor Laboratory Oncology Based Preclinical CRO Product Offered
    Table 114. Living Tumor Laboratory Main Business
    Table 115. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Living Tumor Laboratory Latest Developments
List of Figures
    Figure 1. Oncology Based Preclinical CRO Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Oncology Based Preclinical CRO Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Oncology Based Preclinical CRO Market Size Market Share by Type in 2021
    Figure 7. Oncology Based Preclinical CRO in In Vitro
    Figure 8. Global Oncology Based Preclinical CRO Market: In Vitro (2017-2022) & ($ Millions)
    Figure 9. Oncology Based Preclinical CRO in In Vivo
    Figure 10. Global Oncology Based Preclinical CRO Market: In Vivo (2017-2022) & ($ Millions)
    Figure 11. Global Oncology Based Preclinical CRO Market Size Market Share by Application in 2021
    Figure 12. Global Oncology Based Preclinical CRO Revenue Market Share by Player in 2021
    Figure 13. Global Oncology Based Preclinical CRO Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Oncology Based Preclinical CRO Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Oncology Based Preclinical CRO Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Oncology Based Preclinical CRO Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Oncology Based Preclinical CRO Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Oncology Based Preclinical CRO Value Market Share by Country in 2021
    Figure 19. Americas Oncology Based Preclinical CRO Consumption Market Share by Type in 2021
    Figure 20. Americas Oncology Based Preclinical CRO Market Size Market Share by Application in 2021
    Figure 21. United States Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Oncology Based Preclinical CRO Market Size Market Share by Region in 2021
    Figure 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Application in 2021
    Figure 27. China Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Oncology Based Preclinical CRO Market Size Market Share by Country in 2021
    Figure 34. Europe Oncology Based Preclinical CRO Market Size Market Share by Type in 2021
    Figure 35. Europe Oncology Based Preclinical CRO Market Size Market Share by Application in 2021
    Figure 36. Germany Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application in 2021
    Figure 44. Egypt Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Oncology Based Preclinical CRO Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 53. United States Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 57. China Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 61. India Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 64. France Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 65. UK Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Oncology Based Preclinical CRO Market Size 2023-2028 ($ Millions)

    Crown Bioscience
    Charles River
    ICON
    Eurofins Scientific
    Taconic Biosciences
    Covance
    EVOTEC
    The Jackson Laboratory
    MI Bioresearch
    Champion Oncology
    Wuxi AppTec.
    Xentech
    Living Tumor Laboratory

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape